This review explores the potential of natural products in modulating tau hyperphosphorylation, a pivotal molecular mechanism in Alzheimer's disease onset, by inhibiting kinases, enhancing phosphatase activity, blocking fibril formation, and promoting its disaggregation. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.